MRT68921: Practical ULK1 Kinase Inhibition
2026-08-29
Use MRT68921 to connect ULK1/2 activity with ATG13 phosphorylation and LC3 flux in controlled, time-resolved autophagy experiments. This workflow emphasizes stock handling, pathway-specific controls, and energy-stress interpretation so researchers can distinguish genuine autophagy inhibition from assay artifacts.
Tacalcitol monohydrate: Applied Research Workflows
2026-08-29
Build reproducible Tacalcitol monohydrate workflows for NGF induction, keratinocyte biology, and colorectal cancer combination studies. The same compound supports dose-response screening, VDR-linked mechanism testing, and 5-fluorouracil sensitization while requiring disciplined solvent, light, and timing controls.
SNAI1–PIK3R2/p-EphA2 Axis in Thymic Tumors
2026-08-28
A 2024 study identifies SNAI1 as a transcriptional hub linking epithelial–mesenchymal transition, cancer stem cell-like properties, and macrophage remodeling in thymic epithelial tumors. Integrated genomic, single-cell, chromatin, protein-interaction, and phosphoproteomic analyses place PIK3R2 and phosphorylated EphA2 upstream of GSK3β/β-catenin signaling, offering a mechanistic framework for future preclinical investigation.
MRE11 Lactylation Drives TNBC Radioresistance
2026-08-28
A 2025 Theranostics study identifies lactate-dependent MRE11 lactylation as a DNA-repair mechanism that promotes radiotherapy resistance in triple-negative breast cancer. It further shows that Saikosaponin D activates an HIF1α/HDAC5 pathway to remove this modification, providing a mechanistic framework for metabolic radiosensitization.
Gemcitabine HCl in MRI-Guided Tumor Studies
2026-08-27
Connect Gemcitabine HCl cytotoxicity assays with longitudinal, anatomy-resolved MRI to evaluate treatment response in pancreatic cancer models. This workflow combines mechanism-driven cell experiments with multianimal imaging for more efficient preclinical study enrollment and tumor monitoring.
Chenodeoxycholic Acid: FXR to Renal Translation
2026-08-27
Chenodeoxycholic Acid (CDCA) is more than a bile acid metabolism tool. Emerging evidence connects its activation of FXR to KLF11 transcription and suppression of JAK2/STAT3 signaling in contrast-induced acute kidney injury models. This thought-leadership guide translates that mechanism into practical assay strategy, product-selection considerations, and a disciplined path toward clinical relevance.
Vancomycin hydrochloride: Assay Workflows
2026-08-26
Use Vancomycin hydrochloride as a mechanistically defined positive control for Gram-positive bacteria inhibition, susceptibility testing, resistance profiling, and Clostridium difficile infection models. A time-resolved workflow inspired by semi-mechanistic PKPD modeling can reveal adaptive changes that a single MIC endpoint may miss.
Gastrin I: A Modular GI Assay Strategy
2026-08-26
Gastrin I can serve as a defined stimulus for receptor-to-function studies of gastric acid secretion. This article presents a modular strategy that connects peptide handling, CCK2 signaling, organoid model selection, and assay interpretation without conflating gastric and intestinal systems.
Ruxolitinib, DRP1, and Cell Death in ATC
2026-08-25
The reference study identifies a previously underexplored connection between JAK1/2-STAT3 signaling and mitochondrial fission in anaplastic thyroid carcinoma. It shows that ruxolitinib suppresses STAT3-dependent DRP1 transcription, producing mitochondrial remodeling defects that activate both caspase-dependent apoptosis and GSDME-mediated pyroptosis.
Vancomycin hydrochloride: Assay Workflows
2026-08-25
Vancomycin hydrochloride gives microbiology teams a mechanism-defined benchmark for Gram-positive susceptibility, resistance, and therapeutic studies. This guide translates its D-alanyl-D-alanine activity into practical dilution, time-kill, biofilm-comparison, and infection-model workflows while clarifying where peptide findings should—and should not—be generalized.
Tomivosertib Suppresses Glioblastoma Angiogenesis
2026-08-24
The reference study shows that Tomivosertib inhibits MNK-dependent eIF4E phosphorylation in glioblastoma cells and tumor-associated endothelial cells, reducing tumor growth, survival, and angiogenesis. Its ability to counter temozolomide-associated eIF4E activation supports further evaluation of MNK-eIF4E pathway blockade as a strategy for chemotherapy-resistant glioblastoma.
Novobiocin: Antimicrobial Assay Workflows
2026-08-23
Novobiocin combines bacterial DNA gyrase inhibition with Hsp90-directed activity, making it useful for antibacterial resistance research, antiparasitic screening, and carefully controlled antiviral assays. This workflow-centered guide covers solvent preparation, concentration selection, controls, assay interpretation, and the limitations of translating cell-culture activity into animal or clinical outcomes.
Arachidonic Acid as a Dietary Vaccine Adjuvant
2026-08-22
The reference study shows that dietary Arachidonic Acid can enhance rabies vaccine-induced neutralizing antibodies and improve protection in mice, while oral supplementation accelerated protective antibody expression in human volunteers. Its proposed mechanism links lymph-node arachidonate metabolism, prostaglandin I2, cAMP–PKA signaling, CD86 expression, and B-cell AID activity.
Dorsomorphin 2HCl: AMPK Causality
2026-08-21
Dorsomorphin 2HCl is more than a pathway inhibitor: it is a tool for testing whether AMPK activity is necessary for a translational phenotype. This article examines its role in alcoholic hepatic steatosis research, experimental design, BMP and iron biology, formulation strategy, and the limitations that matter when moving from pathway association to causal evidence.
Berberine, Tuft Cells, and Estrogen-Deficiency Bone Loss
2026-08-21
A 2026 study identifies an intestinal butyrate–GPR41–tuft cell pathway linking berberine exposure to protection from estrogen deficiency-associated bone loss. Using ovariectomized rodents, Trpm5-deficient mice, microbiome profiling, immune analysis, and intestinal organoids, the work advances the gut–bone axis from an association toward a testable mechanistic model.
462 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page